GlaxoSmithKline

GlaxoSmithKline (GSK) is one of the world's leading research-based pharmaceutical and healthcare companies. Headquartered in the UK, We are a global organisation with offices in over 100 countries and major research centres in the UK, USA, Belgium and China.

We at GSK are committed to helping developing countries where debilitating disease affects millions of people and access to life-changing medicines and vaccines is a problem. To meet this challenge, GSK aims to provide discounted medicines where they are needed the most. In 2010, we delivered 1.4 billion vaccine doses to 179 countries.

GSK is one of the few pharmaceutical companies researching both medicines and vaccines for the World Health Organization’s three priority diseases – HIV/AIDS, tuberculosis and malaria.  We have proudly developed some of the leading global medicines in these fields. For example, in November 2009, we launched ViiV Healthcare, a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV

GSK produces medicines that treat major disease areas such as asthma, anti-virals, infections, mental health, diabetes, cardiovascular and digestive conditions. In addition, they are a leader in the important area of vaccines and are developing new treatments for cancer.